Literature DB >> 3437440

Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization.

M D Brogan1, F Shanahan, M Oliver, R H Stevens, S R Targan.   

Abstract

Inflammatory bowel disease patients with mild to inactive disease were studied for their ability to generate pokeweed mitogen responsive anti-tetanus toxoid IgG producing B cells in the peripheral blood 21 days following in vivo tetanus toxoid booster immunization. Compared to normals and disease controls, patients with inflammatory bowel disease had significantly impaired in vitro production of anti-tetanus toxoid antibody during an 8 day pokeweed mitogen stimulated culture period. There was poor correlation between the ratio of helper to suppressor T cells in the peripheral blood and pokeweed mitogen stimulated antibody production. Likewise, there was little correlation between in vitro antibody production and peripheral blood natural killer cell cytotoxic activity. Culture of the patients B cells with normal T cells failed to improve antibody production in vitro. These results indicate that many inflammatory bowel disease patients have an impaired humoral immune response to tetanus toxoid booster immunization. This impaired immune response may be due to an inability to generate B cell precursors of anti-tetanus toxoid IgG producing B cells rather than to abnormal circulating helper or suppressor T cell activity or natural killer cell regulatory activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437440

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  11 in total

1.  The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.

Authors:  R L Deem; S R Targan; A Niederlehner; F Shanahan
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

Review 2.  Vaccination in the Elderly and IBD.

Authors:  Anthony J Choi; Preston Atteberry; Dana J Lukin
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 3.  Vaccination strategies in patients with IBD.

Authors:  Javier P Gisbert; María Chaparro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 4.  Updates in vaccination: recommendations for adult inflammatory bowel disease patients.

Authors:  Khadija Chaudrey; Michelle Salvaggio; Aftab Ahmed; Sultan Mahmood; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  Vaccinating Patients With Inflammatory Bowel Disease.

Authors:  Jason Reich; Sharmeel Wasan; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-09

Review 6.  Efficacy of the vaccination in inflammatory bowel disease.

Authors:  Elisa Carrera; Rebeca Manzano; Elena Garrido
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 7.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

8.  Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy.

Authors:  Ying Lu; Athos Bousvaros
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

9.  Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease.

Authors:  Jason Reich; Sharmeel K Wasan; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

Review 10.  Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.

Authors:  Alicia C Marín; Javier P Gisbert; María Chaparro
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.